Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
|
ACCENTIA BIOPHARMACEUTICALS INC (ABPI) > Segments
|
|
| Biopharmaceutical Products and Services |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Sep-30-12 | Sep-30-11 | Sep-30-10 | Sep-30-09 | Sep-30-08 | Sep-30-07 | Sep-30-06 | Sep-30-05 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | | | | | 14.3 | 13.7 | | |
| Revenue growth | | | | | 3.8% | | | |
| Gross profit | | | | | 5.7 | 9.0 | | |
| Gross margin | | | | | 39.8% | 65.5% | | |
| Sales and marketing | | | | | 0.2 | | | |
| Research and development | | | | | 8.9 | 19.9 | | |
| |
| Total assets | | | | | 13.6 | 28.3 | | 23.6 |
| |
| Revenue Mix | | | | | 89.6% | 75.2% | | |
|